l Summary: Using 231 amniotic fluid samples from a Regional Screening Service, the performance of a monoclonal antibody-based solid-phase immunoradiometric assay (IRMA) for α-fetoprotein was compared with that of a polyclonal antiserum-based solution phase radioimmunoassay (RIA). α-Fetoprotein values determined from these samples by the two methods were in excellent agreement (r = 0.992) and the diagnostic performance of the two assays was identical. However, the IRMA assay displayed a greater working r nge than the RIA, and in addition was more rapid to perform, allowing within-day turnaround of laboratory results.
Introduction

Materials and Metbods
A new, commerci lly available, solid-phase iminuno-α-Fetoprotein analyses radiometric assay (IRMA) for the quantification of Amniotic fluid α-fetoprotein (AFP) was estimated by two techamniotic fluid α-fetoprotein h s been compared with mqu»: a sol tion-phase radioimmunoassay (RIA) which has IRMA (SUCROSEP 1 ) AFP IRMA, Boots-Celltech Diagbeen the ro tine assay used by the Wessex Regional nostics Limited, Slough, U.K.) Amniotic fluid α-fetoprotein screening laboratory for This immunoradiometric assay (IRMA) was perfonned using three vears the manufacturer's recommended protocol: α-fetoprotein standard or unknown sample (50 μΐ) is incubated for two hours at The purpose of this study was to evaluate the labora-~om temperature (15-30 °C) with ' 25 I-labelled'monoclonal j -. . -~ ^t. T-OX^A anUbody to a-fetoprotein (100 μΐ) and solid phase anti-atory and climcal performance of the new IRMA, fetoprotein immunoglobulin (100 μΐ). Throughout this incubawhich incorporates a monoclonal ntibody to α-fetoprotein and requires only a two-hour incubation pe-i) SUCROSEP is a trademark of Boots-Celltech Diagnostics riod thus permitting a within-day assay Service. Limited.
tion, vigorous Orbital agitation (300 -350 min" 1 ) is provided using an agitator (Sucroagitator, Boots-Celltech Diagnostics Limited). At the end of the incubation phase, Separation of free and bound fractions is achieved by the SUCROSEP sucrose layering non-centrifugation technique (1) using a semi-autoraatic instrument (Sucroseparator, Boots-Celltech Diagnostics Limited). This allows assay tubes to be rapidiy separated in 20-tube batches. The overall time taken for assay Separation is approximately 50 minutes.
This solution phase radioimmunoassay (RIA) was also performed using the manufacturer's recommended protocol except that half volume of samples and reagents were employed (the practice in our laboratory for the last 3 years). The assay procedure incorporates an 18 -24 hour incubation of [ 125 Γ|α-fetoprotein and antibody with α-fetoprotein Standard or sample, and Separation of bound and free fractions is achieved by polyethylene glycol precipitation and centrifugation.
Sample analysis
Immediately before assay, each amniotic fluid was diluted with a serum pool of zero α-fetoprotein content. Normally a l in 200 dilution was used, but occasionally a higher dilution amniotic fluid sample was used for both immunoassays and the batches for the two techniques were commenced on the same day. Each amniotic fluid was assayed in duplicate by both techniques.
Calculation of assay results and conversion of afetoprotein units
The radioactivity in all the assay tubes was counted on a multihead gamma counter (LKB 1260 multigamma II) over a 120 second period. α-Fetoprotein values for clinical specimens from both assays were calculated for kU/1 by spline function. The following conversion factor was used for RIA results: l I.U. = 1.21 ng α-fetoprotein [90% confidence interval = 1.02-1.43] (2). These values were then corrected for the sample dilution factor and expressed s MU/1 α-fetoprotein.
Amniotic fluid samples 231 aliquot s of amniotic fluid were studied. These were taken by transabdominal amniocentesis during the second trimester of pregnancy for a variety of clinical indications. These samples were centrifuged and the supernatant either used immediately or stored at -20 °C until analysis.
Normal pregnancies
116 liquors from normal pregnancies were studied. For these pregnancies ultrasound examination revealed no obvious fetal abnormality. The amniotic fluid α-fetoprotein by RIA was within normal laboratory reference limits and there was no evidence of the acetyl cholinesterase isoenzyme band on polyacrylamide gel electrophoresis (3, 4) .
Abnormal pregnancies
109 samples were classified s 'abnormal'. These pregnancies had been terminated and the fetuses conflrmed to have a severe fetal abnormality [54 open spina bifida, 32 anencephaly, 14 exomphalos, 2 gastroschisis, 7 missed abortioii].
'Eq ivocal pregnancies'
Six samples were also included from 'equivocal pregnancies 9 for which the outcome of the pregnancy was a normal infant but the amniotic fluid α-fetoprotein concentration by RIA was either borderline high or significantly elevated.
Statistical methods
Precision profile data (flg. 1) were generated using a 5-parameter curve fitting procedure provided by Boots-Celltech Diagnostics Limited. All other Statistical analysis were perf rmed by using the Minitab Statistics Package 2 ).
Results
Assay reproducibility
The overall reproducibility of the IRMA was greater than that of the RIA. The intra-and inter>assay coefficients of Variation (CV) for the RIA and IRMA are shown in table 1. The greater analytical precision of the IRMA was most noteable at α-fetoprotein concentrations above ~ 200 kU/1, and is apparent from a comparison of intra-assay precision profiles ( fig. 1) . Using a definition of the working r nge of each assay to be the α-fetoprotein concentration associated with an intra-assay CV of < 10%, the IRMA and RIA covered ranges of 3^629 kU/1 and 30-363 kU/1 respectively. These test outcomes based on the IRMA exactly agreed with the classification given by the reference RIA technique. The amniotic fluid α-fetoprotein concentration of 46 of the 52 (88.5%) cases of open spina bifida (gestational age 15-20 weeks) was also greater than the respective multiple of the median cut off levels using the IRMA assay. The remaining 6 cases of open spina bifida had α-fetoprotein values by IRMA which feil below the multiple of the median cut off (false negative results). These same 6 cases were similarly misclassified using the RIA technique. Finally, in the further 6 samples from 'equivocal pregnancies' in which the outcome was in each case a normal infant, the α-fetoprotein level by IRMA was borderline or elevated, again in accordance with the results of the routine RIA.
Discussion
Using amniotic fluid samples collected s part of a regional screening Service, α-fetoprotein values determined by a new, commercially available IRMA were in excellent agreement (r = 0.992) with those determined using the RIA in routine use. However, it was noted that agreement between the two methods was less close at higher levels of α-fetoprotein (> 200 kU/1), with an apparent positive bias towards the IRMA at these elevated concentrations.
Although this divergence did not affect the clinical Utility of either assay, which was excellent in both cases, it is of interest to consider its possible origin more fully. Examination of the intra-assay precision profiles of the RIA and IRMA ( fig. 1 ) reveals that the working r nge of the IRMA is considerably wider than that of the RIA. This wide working r nge, a general feature of IRMAs noted 'by others (e. g. L c. (6)), indicates that at high α-fetoprotein concentrations the analytical precision of the IRMA is markedly greater than that of the RIA. Thus the observed divergence of c^fetoprotein results at the high extreme may, at least in part, be attributable to the relative imprecision of the RIA.
The ability to measure^ using an IRMA, both low and high α-fetoprotein concentrations with similar precision and accuracy may be important and desu> able, especially in view of recent interest in the association between low maternal serum and amniotic fluid α-fetoprotein and Dowrfs syndrome (7).
In summary, the IRMA proved to be a practical, robust and convenient assay for the determination of amniotic fluid α-fetoprotein in a routine laboratory. Though the diagnostic performance of both the IRMA and the RIA was identical, in our opinion the IRMA displayed a number of analytical advantages -noteably an extended working r nge, providing greater confidence at elevated α-fetoprotein values. Furthermore, the IRMA's rel tively short incubation tinie (2 h versus 18h + for the RIA) allows for the convenience of within-day turnaround of laboratory results.
